BioCentury
ARTICLE | Company News

ThromboGenics management update

June 30, 2014 7:00 AM UTC

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Business: Cardiovascular, Ophthalmic Resigned: Chris Buyse as CFO and a director ...